Investors

SHARE PRICE INFORMATION

Amryt Pharma is quoted on the London Stock Exchange’s AIM Market and the Irish Stock Exchange’s Enterprise Securities Market.

Major Shareholders

Major shareholders are as follows (interest as at 1 June 2018).

Name Number of shares Percentage of issued share capital
Software AG-Stiftung 61,272,920 22.30%
Axa Framlington 26,940,370 9.80%
Raglan Road Capital 24,697,347 8.99%
Joseph Wiley 20,994,487 7.64%
Legal & General 14,250,000 5.19%
Amati 13,205,882 4.80%
Rory Nealon 9,664,623 3.52%
Alan Harris 8,869,090 3.23%

There are a total of 274,817,283 shares in issue and no shares held in treasury. Pursuant to the AIM Rules, and insofar as the Company is aware, as at 1 June 2018, 43.49% of the Company’s AIM securities were not in public hands.

Restrictions: there are no restrictions on the transfer of Ordinary Shares.
Takeover Code: the Company is subject to the City Code on Takeovers and Mergers.